About this white paper
Key topics covered in this resource
- the ongoing harmonization in the authorization process by regulatory authorities and ethics committees,
- the evolving role of the EU Legal Representative for sponsors outside Europe,
- the influence of MDR on study conduct, with stricter requirements for safety reporting and post-market surveillance and future developments, including the integration of EUDAMED and the coordinated assessment procedure
